| |
Article Title |
Author(s) |
Pages |
|
|
|
Table of Contents
|
|
iii
|
|
|
|
CME Information
|
|
iv-vi
|
|
|
|
Introduction
Invasive fungal infections (IFIs) have increased in significance in accordance with an increase in the population of at-risk patients, which in turn has been fueled largely by improvements in medical ...
|
John R. Perfect
|
S1-S2
|
|
|
|
Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment
Abstract: Antifungal resistance continues to grow and evolve and complicate patient management, despite the introduction of new antifungal agents. In vitro susceptibility testing is often used to sele...
|
Michael A. Pfaller
|
S3-S13
|
|
|
|
Invasive Mycoses: Diagnostic Challenges
Abstract: Despite the availability of newer antifungal drugs, outcomes for patients with invasive fungal infections (IFIs) continue to be poor, in large part due to delayed diagnosis and initiation of...
|
Luis Ostrosky-Zeichner
|
S14-S24
|
|
|
|
Invasive Mycoses: Strategies for Effective Management
Abstract: Effective management of invasive fungal infections (IFIs) depends on early individualized therapy that optimizes efficacy and safety. Considering the negative consequences of IFI, for some h...
|
Dimitrios P. Kontoyiannis
|
S25-S38
|
|
|
|
The Impact of the Host on Fungal Infections
Abstract: Outcomes of fungal infections in immunocompromised individuals depend on a complex interplay between host and pathogen factors, as well as treatment modalities. Problems occur when host resp...
|
John R. Perfect
|
S39-S51
|
|
